pharmgenomics Flashcards
Pharmacogenomics, definition
how individual genome affects response of RX
Goal is match the drug with person genome
Rates of adverse drug reactions (ADRs) low or high?
ADR- 6-7% in all hos
100K COD/yr
40% in target group will not respond
Name a few causes of ADRs
Interactions Changes d/t age Dx- kidney, liver Lifestyle- alcohol smoking Errors Genetics
Arno Motulsky (1923-2018), not the name, the concept that he came up with
Drug rxn of this type may be caused by otherwis genetic trains or enzyme deficiencies
Define a single nucleotide polymorphism (SNP
single base pair substitions
Variability in enzymes and proteins which lead to drug respone
Human genone 30K genes- over 11m SNPs
Lactose free milk and lactose intolerance, why?
Lactase converts to glucose w/in jejunum
beta galactosidase deficiency (same as Lactase)
SNPs lead to intolerance
ADRs and SNPs in Phase I enzymes, concept
Phase 1 enzymes most important-75% RX biotrans
L/t extra ensyme or too little
PM (poor enzyme metabolier)- produce less morphine
UM- convert too fast L/t ADR, sedation
codeine
CYP 2D6, EM, PM, IM and UM
clopidogrel
Treats stroker and MI
Active metabolits inhibit platet aggregation
5-fluoroacil
inhibits DNA synthesis
dihydropyrimidine dehydrogenase- deficeny reduces anticancer meds
irinotecan
UGT 1A1, topoisomerase I inhibitor
succinylcholine
six steps in muscle firing prolonged apnea
coumarin
bleeding disorder
dose reduction 90% for Theaptuic window
statin
inhibits activion of PT by Vk
ezetimibe/simvastatin
lower cholesterol
isosorbide/hydralazine
lower blood pressure (bp) AA improved
fava beans
divicine and red cell hemolysis
primaquine
hemolytic anemia (red cell hemolysis), glucose-6-phosphate dehydrogenase (G6PD) enzyme in red cells
isoniazid
slow vs rapid acetylators and peripheral neuropathy
slow-AA,whites, fast Asian,
omeprazole
failure to work
azathioprine
TMP enzyme deficiency and death of the patient
inactivates cancer drugs
Phenotypic vs Genotypic testing
Enzyme
vs.
Race
Types of genetic polymorphisms tested for on a drop of blood
CY2D6- PM, UM, EM, IM Inactive enxyme Red. catatlytic activity Inc. amount of enzyme Altered Bio trans-mutant
2FDA Product Labeling requirements for pharmacogenomic information
Adjust dose CYP ensymes
ADR / genotypes
Responder or Non responder